Study Purpose: This study is testing if a special blood test, called ctDNA, can help decide how many treatment cycles patients with a type of lung cancer, called NSCLC, need.
Who Can Join: We are looking for patients aged 18 and older with specific stages (IIA-IIIB) of NSCLC. The cancer must be resectable (can be removed by surgery) and you must have not received treatment before. You need to have good organ function and no recent serious illnesses.
What to Expect: If you join, you will receive 2 cycles of a combination of medicines (immunotherapy and chemotherapy) over 21-day periods. Depending on your test results (ctDNA), you might get 1-2 more cycles or go straight to surgery. Surgery will happen 4-6 weeks after the last treatment. The study involves a few visits over several weeks.
- This study lasts several weeks and includes 2-4 treatment cycles and surgery.
- You will need to visit the clinic for treatments and tests.
- This study is for patients with early to advanced stages of NSCLC.
Note: Talk to your doctor to see if this study might be a suitable option for you.